Who
Alexander Y. Tokman
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, ENDRA Life Sciences; President and CEO, MicroVision.
In numbers
- Trades disclosed
- 94
- Buys
- 18
- Sells
- 1
- Bought
- $251K
- Sold
- $9,000
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 13 Apr 2006
- Last trade
- 2 Mar 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 4 Mar 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —26,921 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —26,921 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 2 Jan 2024filed 23 Feb 2024 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —600 at $0.00 | filing |
| 30 Jan 2023filed 1 Feb 2023 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —9,621 at $0.00 | filing |
| 23 Nov 2022filed 28 Nov 2022 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Bought | $1,70010,000 at $0.17 | filing |
| 22 Aug 2022filed 24 Aug 2022 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Bought | $5,20020,000 at $0.26 | filing |
| 16 May 2022filed 17 May 2022 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Bought | $20K100,000 at $0.20 | filing |
| 28 Mar 2022filed 30 Mar 2022 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —109,323 at $0.00 | filing |
| 3 Jan 2022filed 4 Jan 2022 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 5 Apr 2021filed 7 Apr 2021 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 8 Jan 2021filed 8 Jan 2021 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Sold | $9,00010,000 at $0.90 | filing |
| 4 Jan 2021filed 25 Mar 2021 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 9 Apr 2020filed 13 Apr 2020 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —42,857 at $0.00 | filing |
| 2 Jan 2020filed 6 Jan 2020 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 11 Dec 2019filed 11 Dec 2019 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —89,585 at $0.00 | filing |
| 25 Mar 2019filed 27 Mar 2019 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 2 Jan 2018filed 4 Jan 2018 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,061 at $0.00 | filing |
| 12 May 2017filed 23 May 2017 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
News
MicroVision IRIS Long-Range Lidar Selected by Overland AI for Its Next-Gen IBEX Autonomous Ground VehicleMVIS · californiatelegraph.com · 15 Oct 2026MicroVision Eyes 2027 Revenue Doubling as Lidar Gains Defense, Industrial TractionMVIS · dailypolitical.com · 7 Oct 2026MicroVision Reaffirms 2026 Revenue Outlook, Outlines Commercial Growth, ...MVIS · pr-inside.com · 7 Oct 2026
0 headlines in the last 90 days name Alexander Y. Tokman; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.